Le Poole I C, Boyce S T
Department of Dermatology, University of Cincinnati, College of Medicine, Ohio, USA.
Br J Dermatol. 1999 Mar;140(3):409-16. doi: 10.1046/j.1365-2133.1999.02700.x.
Transforming growth factor (TGF)-beta1 is a multipotent growth factor with an important role in tissue homeostasis. This growth factor regulates cell proliferation, adhesion, migration and differentiation, as well as extracellular matrix deposition. The temporal secretion and activation of latent TGF-beta1 is thus of major importance to physiological and pathological processes and in wound healing and tumour formation. Cultured skin substitutes, as used to treat extensive acute or chronic skin wounds, offer an attractive model to investigate cellular interactions in cytokine and growth factor expression and response in vitro. In the present investigation, expression of TGF-beta1 was analysed in keratinocyte, fibroblast and melanocyte monolayer cultures, as well as in the dermal vs. epidermal components of reconstituted human skin. Immunohistology, enzyme-linked immunosorbent assay (ELISA) and Northern blotting were used to demonstrate expression at the RNA and protein level. In the monolayer cultures, levels of TGF-beta1 synthesized by melanocytes were observed to be considerably elevated when compared with keratinocytes. Most TGF-beta1, however, was secreted by fibroblasts. The relative contribution of the epidermal and dermal components of the skin substitutes to overall TGF-beta1 levels was determined by comparing results obtained for either component in the presence and absence of fibroblasts and keratinocytes. From results obtained by ELISA it was apparent that TGF-beta1 levels generated predominantly by fibroblasts within the skin substitutes were greatly reduced over time in the presence of keratinocytes. Suppression of fibroblast TGF-beta1 expression in the presence of keratinocytes was also demonstrable at the RNA level by Northern blotting. Results obtained by immunohistochemistry suggest that most, if not all, of the growth factor was present in the latent form. It is therefore most likely that the observed effect results from a factor secreted by keratinocytes, which is capable of suppressing TGF-beta1 synthesis by fibroblasts. These results suggest that expression of TGF-beta1 by fibroblasts is downregulated by paracrine actions of keratinocytes in healing skin.
转化生长因子(TGF)-β1是一种多能生长因子,在组织内环境稳定中起重要作用。这种生长因子调节细胞增殖、黏附、迁移和分化,以及细胞外基质沉积。因此,潜伏性TGF-β1的适时分泌和激活对于生理和病理过程以及伤口愈合和肿瘤形成至关重要。用于治疗大面积急性或慢性皮肤伤口的培养皮肤替代物,为研究细胞因子和生长因子表达及体外反应中的细胞相互作用提供了一个有吸引力的模型。在本研究中,分析了TGF-β1在角质形成细胞、成纤维细胞和黑素细胞单层培养物中的表达,以及在重组人皮肤的真皮和表皮成分中的表达。采用免疫组织学、酶联免疫吸附测定(ELISA)和Northern印迹法在RNA和蛋白质水平上证实表达情况。在单层培养物中,观察到黑素细胞合成的TGF-β1水平与角质形成细胞相比显著升高。然而,大多数TGF-β1是由成纤维细胞分泌的。通过比较在有或没有成纤维细胞和角质形成细胞存在的情况下皮肤替代物的表皮和真皮成分对总TGF-β1水平的相对贡献来确定。从ELISA获得的结果明显看出,在角质形成细胞存在的情况下,皮肤替代物中主要由成纤维细胞产生的TGF-β1水平随时间大幅降低。Northern印迹法在RNA水平上也证实了在角质形成细胞存在的情况下成纤维细胞TGF-β1表达受到抑制。免疫组织化学获得的结果表明,大部分(如果不是全部)生长因子以潜伏形式存在。因此,观察到的效应很可能是由角质形成细胞分泌的一种因子引起的,该因子能够抑制成纤维细胞合成TGF-β1。这些结果表明,在愈合皮肤中,角质形成细胞的旁分泌作用下调了成纤维细胞TGF-β1的表达。